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Phosphorylation of GAP-43 and the Effect on APP Processing 
 
 
Kaitlynn Tracy and Eric M. Norstrom* 
Department of Biological Sciences 
 
 
ABSTRACT The phosphorylation of Growth Associated Protein may affect the occurance of 
interaction between GAP-43 and the Amyloid Precursor Protein. By synthesizing mutants of the GAP-43 
protein, the amount of C-terminal fragments of APP that results from the interaction could be observed 
under various conditions. An alanine mutant (S41A) and an aspartate mutant (S41D) and the wild type 
GAP-43 were all co-expressed with APP in moues neuroblastoma cells and analyzed on a Western blot.  
The mutant used to block phosphorylation, S41A, showed a greater occurance of interaction with APP 
while the mutant that was created to mimic the effect of phosphorylation, S41D, showed less interaction. 
Further study of this research would include verifying the interaction of the two proteins through a co-
immunoprecipitation experiment and determining the mechanism by which GAP-43 mediates changes in 
APP metabolism. 
 
INTRODUCTION 
Alzheimer’s Disease (AD) is the sixth leading 
causes of death in the United States and the most 
common form of dementia, causing problems with 
memory, cognition, and behavior (5). The disease is 
characterized by a buildup of amyloid plaques in 
the brain, which is associated with a decrease in 
efficiency of neuronal communications (6). There is 
no cure or effective treatment for the disease 
(Figure 1). The plaques that damage the brain’s 
tissues are formed by fibrils of a metabolite of a 
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protein called Amyloid Precursor Protein (APP). 
Located on the membrane of cells, the neuronal 
form of APP is a 695 amino acid protein that can 
be cleaved in several locations by complex 
metabolic processing (7). If the protein is 
cleaved at the α-site by the enzyme α –secretase, 
then a second cleavage by γ –secretase yields a 
soluble protein that is non-pathogenic to the 
cells around it (Figure 2). However, if the 
protein is cleaved first at the β site by β-
secretase, then subsequent cleavage by γ –
secretase releases β-amyloid (Aβ) peptides, 
which have a propensity to aggregate and form 
fibrils and plaques, leading to pathologies 
related to AD (7;9). Thus, it is of significant 
interest to identify and explore proteins that may 
bind to and influence the processing of APP (2). 
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Growth Associated Protein (GAP
cytosolic protein involved in cell growth, neuronal 
axon extension, and molecular mechanisms of 
learning and memory (3). Recently, our lab has 
found that GAP-43 can interact with APP and alter 
its rate of metabolism, an effect that 
dependence on membrane localization
factor that affects the functioning of GAP
phosphorylation on a serine residue, wh
regulatory effect on GAP-43 membrane 
localization (4;8). Thus, since APP is a 
transmembrane protein, I hypothesize that 
phosphorylation of GAP-43 may be a critical 
factor in its modulatory effect on APP metabolism.
Figure 1. As Alzheimer’s develops from early to late 
stages, a buildup of plaques composed of 
in greater density throughout the brain.
Alzheimer’s Association) 
 
Figure 2. Aβ is formed from the proteolytic
of the amyloid precursor protein (APP). APP has 
multiple metabolic fates, only one of which leads to 
the formation of Aβ. (Figure adapted from O’Brien and 
Wong, 2011) 
-43) is a 
suggests 
 (1;3). One 
-43 is 
ich has a 
 
Aβ are visible 
 (Figure source: 
 
 processing 
OBJECTIVES
The purpose of this research is to determine 
whether GAP-43 phosphorylation plays a role in 
modulation of APP processing. This is 
producing phosphorylation deficient and 
mimetic mutants of GAP-43 and co
them with APP in cultured cells. Following that, 
an assay will be used to measure the i
the Wild-type, phospho-deficient, and phospho
mimetic GAP-43 on the APP metabolic 
processing by comparing the amount of C
terminal fragments that result for each given 
sample. A reduction of C-terminal fragments 
would indicate a greater interaction between 
APP and GAP-43. 
 
METHODS 
To test the effect of phosphorylation on the GAP
43 protein, molecular and cell culture techniques 
were used to co-express APP with a GAP
carries a mutation rendering it unable to be 
phosphorylated. The metabolism of APP in this 
condition will be compared to samples in which 
APP has been co-expressed with a 
of GAP-43. As an additional condition, a form of 
GAP-43 that has been mutated to mimic the 
phosphorylated state will also be tested. 
To begin the experiment, site-directed mutage
was enacted to change the phosphorylation site of 
GAP-43. Mutagenesis is a laboratory technique 
that changes the genetic information on a strand of 
DNA in order to alter the makeup and functions of 
the protein that is expressed from the DNA code
(Figure 3). For this experiment the DNA was 
mutated to alter a serine residue
(the consensus phosphorylation site of GAP
an alanine, which does not possess the required 
hydroxyl group onto which the phosphate is added 
via an enzyme-mediated dehydration reaction, 
preventing the mutant protein from being 
phosphorylated. In parallel reactions, the same 
codon was changed to aspartate 
charge and structural profile to that of phosphate 
and can act as a phospho-mimetic (
 
tested by 
-expressing 
mpact of 
-
-
-
-43 that 
wild type form 
  
nesis 
 
 at amino acid 41 
-43) to 
thus 
that has a similar 
D).  Once 
2
DePaul Discoveries, Vol. 4 [2015], Iss. 1, Art. 14
https://via.library.depaul.edu/depaul-disc/vol4/iss1/14
  
cloning of the mutants was completed, the GAP
43 mutant and the wild type GAP-43 protein
then co-expressed with APP in cultured mouse 
neuroblastoma (N2a) cells and the metabolites of 
APP were measured by Western blot analysis. 
This procedure is conducted through 
polyacrylamide gel electrophoresis (SDS
which separates the proteins by their 
allowing for the identification of the cleaved APP 
products by their lengths.  After the 
electrophoresis, the proteins were transferr
nitrocellulose membrane and incubated with 
antibodies that bind to APP. Then, using 
chemiluminescence, the antibodies that were 
attached to the APP metabolites were detected and 
quantified, and compared.  
Figure 3. Polymerase Chain Reaction (PCR)
to amplify specific DNA sequences of the GAP
open reading frame.  
RESULTS 
The first step of the procedure was to amplify 
the specific DNA sequences of the GAP
reading frame (ORF). Primers included codons 
to mutate S41 to either alanine
aspartate (S41D). Gels were run and imaged to 
confirm that each mutant contained both the 
forward and reverse primers from the first round 
of PCR, and the full ORF transcript in the 
second round of the reaction. The images from 
the gel are shown for the alanine mutant belo
(Figure 4)(Figure 5).  Each fra
confirmed based on its length in base pairs. 
Then, each sample was digested to run on a gel 
in order to confirm the presence of the inserts in 
each sample. As shown below, the first, th
-
s were 
-PAGE), 
relative size, 
ed to a 
 was used 
-43 
-43 open 
 (S41A) or 
w 
gment was 
ird, 
and fourth samples from each mutant contained 
the templates and were suitable for the 
subsequent procedures (Figure 6
From there, the samples were sent to a 
laboratory to have their sequences confirmed.  
Chromatograms were returned for each sample,
showing the specific nucleotide bases in each 
piece of DNA. For the wild type GAP
codon at the forty-first residue is AGC 
a serine amino acid. However, in the first sample 
the codon is GAC. This confirmed the aspartate 
codon in the first sample (Figure 8
the codon in the second sample was GCC, wh
codes for alanine (Figure 7). 
With the sequences confirmed, the wild type and 
mutants were co-expressed with APP in cultured 
mouse neuroblastoma (N2a), and the metabolites 
were measures with a Western Blot analysis. 
Additionally, the presence of GAP
confirmed in the Western Blot procedure to 
ensure that all samples contained the protein. 
The chemiluminescence image is shown below
(Figure 9). The Western Blot shows that there 
was a greater reduction of C-terminal fragments 
when the APP was co-expressed with S41A than 
when it was co-expressed with the GAP
type. The S41A mutant was unable to be 
phosphorylated, which resulted in 
C-terminal fragments than the 
protein. This would suggest that there was an 
increase in interaction between the mutated 
protein and APP than with the wild type GAP
43. 
Attempting to mimic the effects of 
phosphorylation in the S41D mutant did not 
result in the same amount of functional 
interaction as wild type GAP
the increase of C-terminal fragments of APP on 
the Western Blot. These speculatie 
suggest that GAP-43 associates with APP 
primarily in its non-phosphorylated form. 
Phosphorylation at serine 41 may thus serve as a 
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-43 was 
 
-43 wild 
a reduction of 
wild type GAP-43 
-
-43, as shown by 
data readings 
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regulatory modification that inhibits the 
APP/GAP-43 complex formation. 
Further study of the topic would include a 
replication of the preliminary results. A 
quantitative determination of the relative 
population of phosphorylated and 
unphosphorylated GAP-43 would be calculated, 
and a co-immunoprecipitation of APP with wild
type and mutant GAP-43 would be conducted. 
 
Figure 4. PCR Round 1, Generating S41A mutant 
containing DNA 
 
Figure 5. PCR Round 2, Combining round 1 products 
as a template to generate full ORF transcript. 
 
-
 
 
 
 
Figure 6. Screening of S41A and S41D clones.
 
Figure 7. The chromatogram indicates that the 
codon for serine (AGC), was replaced with GCC 
which codes for an alanine.  
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Figure 8. The chromatogram indicates that the 
codon for serine (AGC), was replaced with GAC 
which codes for an aspartate.  
Figure 9. The Western Blot shows that there was a 
greater reduction of C-terminal fragments when the 
APP was co-expressed with S41A than when it was 
co-expressed with the GAP-43 wild type.
presence of GAP-43 was confirmed in the bottom 
bands. The band inbetween APP CTF and APP
length present in the mutants was determined to be 
background and noise and excluded from futher 
experimentation.  
 
 
 
 
 
 The 
-Full 
EXPERIMENTAL DESIGN
Generation of Mutant GAP
Crossover PCR mutatgenesis was performed to 
generate GAP-43 mutants from wild
43. Template DNA for the reactions was 
plasmid pAG3 containing the ORF of GAP
Primers containing mutations at codons 
indicated in poster were used for the 
amplification reactions in the first round, the 
products of which were used as the template for 
the second cross-over round using flanking 
primers. Products of round 2 were digested and 
ligated into pAG3 vector, transformed into 
DH5α cells and incubated over night (o/n) at 
37°C on LB-agar plates containing the selective 
antibiotic ampicilin.  Isolated colonies were 
selected grown in 3mL LB Broth,
ampicilin at 37°C on a shaker at 250rpm 
overnight.  Plasmids were isolated using alkali 
lysis followed by matrix capture using the 
GeneJET Plasmid Miniprep Kit (Ferm
Plasmid DNA was digested with 
BamHI and HinDIII to detect the presence of an 
insert. Positive colonies were submitted for 
sequencing at the University of Chicago 
sequencing facility. 
Cell culture: N2a mouse neuroblastoma 
cells were grown in DMEM with 10% FBS and 
1% penicillin/streptomycin and incubated at 
37°C under 5% CO2.  Cells were passaged 1:10 
every 3-4days.   
Transfection: N2a cells were transiently 
cotransfected with APP and either GAP
GAP-43 S41A, or GAP-43 S41D or GFP as a 
control protein. Transfection was performed in 
30mm culture plates at a cell confluence of 
approximately 80% using Lipofectamine 2000 
(Invitrogen). Coexpression was allowed for 
40hrs at 37°C under 5% CO2. 
Cell lysis: Cells were lysed on ice using 
200uL lysis buffer (50mM Tris pH 7.4, 150mM 
NaCl, 1mM EDTA, 0.5% IGEPAL, 0.5% 
 
-43: 
-type GAP-
the 
-43. 
 with 50µg/mL 
entas). 
the enzyme 
-43, 
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Na:DOC and a protease inhibitor cocktail). 
Insoluble material was removed by 
centrifugation at 16,000 x g and the resultant 
supernatants were transferred into new 
microcentrifuge tubes and the pellets discarded. 
The lysis contents were analyzed for protein 
concentration using the BCA method (Pierce). 
Western blot: Lysates samples were 
boiled in Laemmli sample buffer and analyzed 
by Western blot after poly-acrylamide gel 
electrophoresis, on hand-poured gradient 
tris/tricine gels. Proteins were transferred onto 
polyvinylide fluoride membranes (Bio-Rad) and 
washed 3 times with phosphate buffered saline 
containing 0.1% tween-20 detergent (PBST) for 
5 min each and then blocked with 5% milk in 
PBST for 1hr at room temperature with rocking.  
The membranes were then transferred to 
containers containing the appropriate primary 
antibody and incubated on a rocker at 4°C o/n 
and then washed 3x for 5 min each with PBST 
and incubated with the appropriate secondary 
antibody with rocking for 1hr at room 
temperature.  The membranes were then washed 
4 times for 5 minutes each with PBST and rinsed 
with distilled water.  Immunoreactivity was 
visualized using SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific) 
and read using FluorChem HD2 software or 
OmegaLum G CCD imager.
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